World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

IMPACT OF THE CHOICE OF EXCIPIENTS (PREFORMULATION/FORMULATION) ON THE DISCRIMINATING POWER OF A DISSOLUTION METHOD

Pascal St-Laurent* and François-Xavier Lacasse

ABSTRACT

The dissolution test is a test that is mandatory for any molecular entity formulated under a solid dosage form such as hard/ soft gelatin capsules or tablets. Performing a dissolution test is not, per se, a challenge since dissolution apparatus type one (1) or two (2) have been well designed for this purpose. Numerous dissolution methods exist for generic and innovator drugs. These methods are developed daily. During the 80’s and the beginning of the 90’s, drug substances were classified highly soluble and permeable (BCS1); Formulation and dissolution method developments were not as challenging as they are nowadays. However, over the past 20 years, since molecules have become more and more hydrophobics, not soluble (BCS 2, 4) and permeable (BCS2) or not (BCS4), the formulation development became increasingly important to make these drug substances more soluble or at least to show a “workable” solubility rate for dissolution method development. It is one thing to generate solubility profile for a drug substance, but it is completely different for a drug product (formulated product) to get the same profile. The best scenario would be that the formulation is not held responsible for any differences in the drug substance’s profile. The authors of this short communication, an analytical chemist, and a formulator show more than 40 years of experience in drug development and have been through these challenges with different kinds of drug substances. They will try to expose, based on their experiences, expertise and proven track records that formulation development combined with dissolution method development should be considered artistry, as getting a discriminatory dissolution method is not as easy as it seems.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR